Literature DB >> 25621556

Evaluation of bone formation after grafting with deproteinized bovine bone and mineralized allogenic bone.

Kyung-Nam Moon1, Su-Gwan Kim, Ji-Su Oh, Chun-Sung Kim, Sung-Chul Lim, Mi-Ae Jeong.   

Abstract

PURPOSE: The purpose of this study was to evaluate the ability of new bone formation of deproteinized bovine bone (Bio-Oss) and mineralized allogenic bone (Tutoplast).
MATERIALS AND METHODS: Sixty rats were divided into control and experimental groups (groups 1 and 2): control group, unfilled control; group 1, Bio-Oss; group 2, Tutoplast, respectively. The animals were killed after 6 and 12 weeks, and newly formed bone was analyzed histomorphometrically.
RESULTS: In the control group, some new bone formed in the rim of the defect area. In the group 1, newly formed bone was thinner than the adjacent normal bone, and Bio-Oss particles were observed. In the group 2, showed a pattern of gradual fusion with adjacent bone, as well as particles in some areas, similar to the Bio-Oss-treated group. In the 12-week groups, the amount of new bone formation was significantly higher in the experimental groups than in the control group, and it was significantly higher in group 2 than in group 1.
CONCLUSION: Although Tutoplast and Bio-Oss graft materials seem to be useful for bone grafts, Tutoplast showed more active new bone formation than Bio-Oss.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25621556     DOI: 10.1097/ID.0000000000000185

Source DB:  PubMed          Journal:  Implant Dent        ISSN: 1056-6163            Impact factor:   2.454


  2 in total

Review 1.  Manufacturing artificial bone allografts: a perspective.

Authors:  Emma Steijvers; Armaan Ghei; Zhidao Xia
Journal:  Biomater Transl       Date:  2022-03-28

2.  Evaluation of bone allograft processing methods: Impact on decellularization efficacy, biocompatibility and mesenchymal stem cell functionality.

Authors:  Alexander Rasch; Hendrik Naujokat; Fanlu Wang; Andreas Seekamp; Sabine Fuchs; Tim Klüter
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.